Clinical Trials Browser

Phase 1 × Bile Duct Neoplasms × LY6K protein, human × Clear all

NCT00624182 2015-06-23

Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer

Phase 1 Suspended

Gastrointestinal

Bile Duct Neoplasms